Healthcare -
Biotechnology - NASDAQ - US
$ 0.356
-49.1 %
$ 129 M
Market Cap
-0.48
P/E
LXRX - TOTAL EQUITY
Total Equity LXRX - Lexicon Pharmaceuticals, Inc.
93.1 M
LAST VALUE
43.62%
2 YEAR CAGR
15.59%
5 YEAR CAGR
7.66%
10 YEAR CAGR